NCT03853226

Brief Summary

In surgical patients considered with "high cardiovascular risk", by their field or by the nature of their intervention, it is recommended to use hemodynamic monitoring including a continuous measurement device of arterial pressure and cardiac output (CO). However, targeting mean arterial pressure (MAP) with boluses of selective peripheral vasopressors (without positive inotropic or chronotropic effects) could have deleterious effects on CO. Thus, it seems important to use a combined analysis of MAP and CO to estimate the afterload-related cardiac performance (ACP) The investigators recently proposed a cardiac afterload monitoring, in the descending thoracic aorta, based on a combined analysis of flow velocity signal recorded by trans-oesophageal Doppler and aortic pressure, the Velocity-Pressure Loop (VP Loop). VP Loop, and its derived indicators, especially Global AfterLoad Angle (GALA), could be useful during hemodynamic management for continuous cardiac afterload monitoring. However, in cardiology unit, cardiac afterload is usually measured at the ascending aorta behind the aortic valves. The main objective of this study is to compare VP Loop parameters build in the ascending and descending thoracic aorta according to patient cardiovascular risk factors.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2014

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 5, 2014

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 25, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 25, 2016

Completed
2.9 years until next milestone

First Submitted

Initial submission to the registry

February 22, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 25, 2019

Completed
Last Updated

February 27, 2019

Status Verified

February 1, 2019

Enrollment Period

2.1 years

First QC Date

February 22, 2019

Last Update Submit

February 25, 2019

Conditions

Keywords

After-load cardiac performancehigh cardiovascular risksurgical patient

Outcome Measures

Primary Outcomes (3)

  • Measure of aortic pressure in the ascending aorta and in the descending thoracic aorta in mmHg (PAo)

    For all patients, aortic pressure will be collected at the end of the procedure during catheter withdrawal

    Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)]

  • Aortic velocity in the ascending aorta in cm/s (VAasc.)

    For all patients, aortic ascending velocity will be collected at the end of the procedure during catheter withdrawal

    Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)

  • Aortic velocity in the descending aorta in cm/s (VAdes.)

    For all patients, aortic descending velocity will be collected at the end of the procedure during catheter withdrawal

    Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)]

Interventions

For all patients, data from trans-esophageal Doppler, trans-thoracic echocardiography (TTE) and hemodynamic data are collected at the end of the procedure. During catheter withdrawal, pressure waveforms are recorded at two predefined aortic locations: in the ascending aorta and in the descending thoracic aorta just in front of the esophageal Doppler probe.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with scheduled an elective interventional neuroradiology procedure under general anesthesia requiring a continuous monitoring of mean arterial pressure and cardiac output.

You may qualify if:

  • Patients \> 18 years scheduled an elective interventional neuroradiology procedure under general anesthesia requiring a continuous monitoring of mean arterial pressure and cardiac output.
  • oral agreement obtained from each patient before anesthesia

You may not qualify if:

  • age \<18 years
  • an emergency procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Joaquim MATEO, MD

    HLariboisière

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

February 22, 2019

First Posted

February 25, 2019

Study Start

January 5, 2014

Primary Completion

January 25, 2016

Study Completion

March 25, 2016

Last Updated

February 27, 2019

Record last verified: 2019-02